Clinical Trials Sponsored by Arpida AG

Total 2460 results

elbion AG

Terminated

ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

Overactive Bladder | Urinary Incontinence

Sweden, Germany, Poland
Weleda AG

Unknown

Bryophyllum vs. Nifedipine

Tocolysis

Switzerland
elbion AG

Terminated

ELB139 Given Orally to Patients With Concurrent Panic Disorder, Challenged by CO2 Inhalation After a Single Dose and One Week of Treatment

Panic Disorder

Germany, Netherlands
Abbott Rapid Diagnostics Jena GmbH

Completed

Clinical Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel

COVID-19 | Influenza A | Influenza Type B

United States
Abbott Rapid Dx

Recruiting

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use

COVID-19 | Influenza A | Influenza Type B

United States
Abbott Rapid Dx

Completed

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Product Using Mid-Turbinate Nasal Swabs

COVID-19 | Influenza A | Influenza Type B

United States
Abbott Rapid Dx

Completed

Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.

COVID-19 | Influenza A | Influenza Type B

United States
Ariad Pharmaceuticals
Takeda

Active, not recruiting

A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (ALTA-2)

ALK-positive Advanced NSCLC

Korea, Republic of, United States, Spain, Taiwan, Canada, Hong Kong, China, Sweden, Australia, Italy, Japan, Germany, Netherlands, France, Austria
Ariad Pharmaceuticals

Completed

A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib

Carcinoma, Non-Small-Cell Lung
Ariad Pharmaceuticals

Completed

Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL) (PACE)

Chronic Myeloid Leukemia | Ph+ Acute Lymphoblastic Leukemia

France, Belgium, Australia, Singapore, Germany, Spain, United Kingdom, Netherlands, Italy, Korea, Republic of, Sweden
Ariad Pharmaceuticals

No longer available

An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer

Carcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced Malignancies

United States
Tetec AG
Winicker Norimed GmbH; Aesculap AG

Active, not recruiting

Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients (JUNOVO)

Cartilage Disease

Germany
Tetec AG
Winicker Norimed GmbH; Aesculap AG

Completed

Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects (RENOVO)

Cartilage Disease

Germany
SpineWelding AG
ISS integrated Scientific Services AG

Terminated

A Feasibility Study to Evaluate the TURRIS Facet Fusion System in Lumbar Spinal Surgery

Spinal Disease

Switzerland
Ypsomed AG
Diabetes Center Berne Research AG

Completed

YpsoPump Occlusion Detection Algorithm: Collection of Real-world Data for In-silico Evaluation of a New Software Algorithm to Refine Occlusion Detection in Subjects With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Diabetes Mellitus, Type 1

Germany, Switzerland
Tetec AG
Winicker Norimed GmbH; Aesculap AG

Completed

Non-interventional Study With NOVOCART® Basic in Patients Treated for Cartilage Defects in the Knee With MAC (NBasic)

Cartilage Diseases

Germany, Switzerland
Anjali Raja Beharelle
MediService AG

Enrolling by invitation

Collabree: A Remote Intervention to Improve the Regularity of Medication Intake

Hypertension | Medication Adherence

Switzerland
University Hospital Tuebingen
BASF; AUDI AG; BMW AG; Dachser Intelligent Logistics; Daimler AG; Deutsche Post AG; Iturri... and other collaborators

Completed

Work Physiological-Biomechanical Analysis of a Passive Exoskeleton to Support Occupational Lifting and Flexing Processes (ADVANCE)

Passive Upper-limb Exoskeleton

Germany
Abbott Rapid Dx

Not yet recruiting

Clinical Evaluation of the ID NOW™ CT/NG Test

Asymptomatic Condition | Neisseria Gonorrheae Infection | Chlamydia Trachomatis Infection

United States
Abbott Rapid Dx

Completed

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel

COVID-19 | Influenza A | Influenza B

United States
Abbott Rapid Dx

Completed

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Rapid Panel Professional Use Device and the Panbio™ COVID-19/Flu A&B Rapid Panel Self-Test Device

COVID-19 | Influenza A | Influenza Type B

United States
Ariad Pharmaceuticals

Completed

A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)

Chronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Japan
Ariad Pharmaceuticals

Terminated

A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid Leukemia (OPTIC-2L)

Chronic Phase Chronic Myeloid Leukemia

Belgium
Ariad Pharmaceuticals

Completed

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants (ALTA-1L)

Carcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced Malignancies

United States, Canada, Germany, Spain, Taiwan, Korea, Republic of, Switzerland, Hong Kong, Singapore, Italy, Sweden, United Kingdom, France, Netherlands, Denmark, Australia, Norway, Austria, Luxembourg
Ariad Pharmaceuticals

Completed

A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)

GIST

United States
Ariad Pharmaceuticals

Approved for marketing

Expanded Access Program of Ponatinib

Chronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

United States
Apira Science, Inc.

Completed

Treatment of Androgenetic Alopecia in Males and Females (LLLT)

Androgenetic Alopecia

United States
Apica Cardiovascular Limited

Completed

A Pilot Study to Evaluate the Safety and Efficacy of the Apica Access, Stabilization and Closure (ASC™) Device

Aortic Valve Stenosis
iOMEDICO AG
Bristol-Myers Squibb; Roche Pharma AG

Completed

Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology (INFINITY)

Advanced Solid Tumors or Hematologic Malignancies

Germany
MoonLake Immunotherapeutics AG

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa
Alvotech Swiss AG

Not yet recruiting

Pilot Study of AVT16 in Healthy Adult Subjects

Healthy

New Zealand
Lumendo AG
Avania

Not yet recruiting

A Study to Assess the Clinical Success of Root Canal Treatment Using Novel Obturation Material.

Endodontic Treatment

Turkey
Advanced Bionics AG

Recruiting

Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation

Cochlear Hearing Loss

Germany
Advanced Bionics AG

Recruiting

Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant

Cochlear Hearing Loss

Germany
DCB Research AG

Not yet recruiting

Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes (TIMES)

Diabetes Mellitus, Type 1
Noorik Biopharmaceuticals AG

Recruiting

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Liver Cirrhosis | Acute Kidney Injury | Hepatorenal Syndrome | Ascites Hepatic

India
Versantis AG

Recruiting

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™

Acute-On-Chronic Liver Failure | Ascites

Germany, Spain, Belgium, United States, France
iOmx Therapeutics AG

Recruiting

A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

Solid Tumor

Spain, Belgium
Brust-Zentrum AG

Not yet recruiting

Patient Reported Outcomes After Oncoplastic Breast Conserving Surgery

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer in Situ
Vaderis Therapeutics AG

Recruiting

Assess Safety and Efficacy of VAD044 in HHT Patients

Hereditary Hemorrhagic Telangiectasia (HHT)

United States, Spain, France, Belgium, Netherlands, Italy
T3 Pharmaceuticals AG

Recruiting

First in Human Study of T3P-Y058-739 (T3P)

Advanced Solid Tumor

United Kingdom, Switzerland
Ivoclar Vivadent AG

Not yet recruiting

Lithium Disilicate Crowns Study

Dental Trauma | Caries

United States
Reis Augenklinik AG

Not yet recruiting

Myopia Prevention With Reading Glasses (SMART2)

Myopia

Liechtenstein
Lallemand Pharma AG

Not yet recruiting

Impact of Symbiofilm On Nasal Microbiota (ISONAM)

Rhinosinusitis Chronic | Microbiome
Advanced Bionics AG

Recruiting

Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss

Cochlear Hearing Loss

Germany
Heidelberg Pharma AG

Recruiting

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Multiple Myeloma | Plasma Cell Disorder

United States, Germany, Poland, Hungary
Advanced Bionics AG

Recruiting

PMCF on Safety and Performance of HiResTM Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss

Cochlear Hearing Loss

Germany
Geistlich Pharma AG

Recruiting

Evidence For Fusion In Spine With Orthoss® (EFFISO)

Lumbar Spinal Stenosis | Lumbar Disc Degeneration | Lumbar Spondylolisthesis Involving L4-L5 | Lumbar Spondylolisthesis Involving L5-S1

Germany
Alvotech Swiss AG

Active, not recruiting

Comparative, Multicenter Study in Subjects With Rheumatoid Arthritis, ALVOFLEX (ALVOFLEX)

Rheumatoid Arthritis

Bulgaria
TRB Chemedica AG

Active, not recruiting

Routine Application of Ostenil® in Patients With Gonarthrosis

Gonarthrosis

Germany

Clinical Trials Sponsored by Arpida AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sweden

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations